Ajanta Pharma Limited
AJANTPHARM
Rangering i aksjer
#3707
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aksjekurs
$36.33
Markedsverdi
$4.54B
Endring (1 dag)
-0.20%
Endring (1 år)
30.66%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Kategori
Healthcare
P/S-forhold for Ajanta Pharma Limited (AJANTPHARM)
P/S-forhold per October 2026 TTM: 7.22
Ifølge Ajanta Pharma Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 7.22. Ved slutten av 2024 hadde selskapet et P/S-forhold på 6.70.
P/S-historikk for Ajanta Pharma Limited fra 2005 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 7.22 | 2.45% |
| 2025 | 7.05 | 5.24% |
| 2024 | 6.70 | 61.85% |
| 2023 | 4.14 | -13.17% |
| 2022 | 4.77 | -13.04% |
| 2021 | 5.48 | 17.77% |
| 2020 | 4.65 | 3.04% |
| 2019 | 4.52 | -24.60% |
| 2018 | 5.99 | -25.91% |
| 2017 | 8.08 | 11.33% |
| 2016 | 7.26 | -2.23% |
| 2015 | 7.43 | 150.83% |
| 2014 | 2.96 | 77.93% |
| 2013 | 1.66 | 110.13% |
| 2012 | 0.79 | 70.54% |
| 2011 | 0.46 | -11.05% |
| 2010 | 0.52 | 203.72% |
| 2009 | 0.17 | -43.53% |
| 2008 | 0.30 | -6.40% |
| 2007 | 0.33 | -12.74% |
| 2006 | 0.37 | 11.05% |
| 2005 | 0.34 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -2.29% |
IN
|
